当前位置: 首页 > 期刊 > 《医学信息》 > 2025年第15期
编号:2393648
阿利西尤单抗联合阿托伐他汀对顽固性高脂血症患者血脂水平及超敏C反应蛋白的影响
http://www.100md.com 2025年8月27日 医学信息 2025年第15期
     中图分类号:R589.2 文献标识码:A文章编号:1006-1959(2025)15-0047-05

    DOI:10.3969/j.issn.1006-1959.2025.15.009

    Effect of Alirocumab Combined with Atorvastatinon BloodLipidLeveland High-sensitivity C-reactive Protein in Patientswith RefractoryHyperlipidemia

    LONGTao,DENGQiong,WANG Shicheng (TheSecond Departmentof Internal Medicine,Wanzai County HospitalofTraditional Chinese Medicine, Wanzai,Jiangxi,China)

    Abstract:ObectieTessthofloabdihoastatilodlipidlelandsiteacioe patientswithrefractoryhyperlipidemiaMetodsAtotalf66patientsithrefractoryhyperlipidemiaadmitedtanaiCountyHospitalf TraditionalChineseMedicinefromJauary22toJauaryO24wereseletedasthereseachbjectsAcordingtotherandomnumbertable method,theyeeddedtootolodseatioitatitsinchouTheotrolgopasreatedisati oraly,andtheatiooareatedittoastatiobditloabetioecallodlidlees [ile( factor levels [tumor necrosis factor- ?α∝ (TNF- -α ),high-sensitivity C-reactive protein (hs-CRP),interleukin-6 (IL-6),hemorheology (plasma viscosity, wholebloodloutvisosityolelodigutvisositymatorit),deseeactiosalaninaiotrasferase(ae aminotrasfesad Results The total efective rateof the observation group was higher than that of thecontrol group( Plt;0.05) .Aftertreatment ......

您现在查看是摘要页,全文长 12318 字符